| Particulars |
|
|
|
| Company Name
| Kabra Drugs Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
10.08 |
B.V. (₹) |
3.30 |
| Sales(₹ Cr.) |
0.00 |
NP (₹ Cr.) |
-0.74 |
| NP Var% |
-118.00 |
Div% |
0.00 |
| CPS(₹) |
-0.70 |
EPS (₹) |
-0.70 |
| Traded Value(₹ Lakhs) |
0.25 |
52 Week High |
10.00 |
| 52 Week Low |
5.00 |
Price BSE |
10.00 |
| Price NSE |
0.00 |
Market Capital (₹ Cr.) |
9.67 |
| P/C Ratio |
-13.70 |
P/E Ratio |
-13.70 |
| Price Vs.BV |
3.03 |
|
| Latest Quarter |
| Year End |
202409 |
Sales (₹ Cr.) |
0.00 |
| NP(₹ Cr.) |
-0.40 |
NP Var % |
-196.00 |
| Trailing Twelve Months |
| Year End |
202409 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
-1.42 |
| NP Var% |
-209.65 |
EPS |
0.00 |
| PE |
0.00 |
|
|